Pegasus Partners Ltd. Amgen Inc Transaction History

Pegasus Partners Ltd.

$1.07 Billion
Q3 2024

A detailed history of Pegasus Partners Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Pegasus Partners Ltd. holds 935 shares of AMGN stock, worth $255,638. This represents 0.03% of its overall portfolio holdings.

Number of Shares

935

Previous 918 1.85%

Holding current value

$255,638

Previous $286,000 5.24%

% of portfolio

0.03%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$309.38 - $337.38 $5,259 - $5,735	17 Added 1.85%	935 $301,000
Q2 2024 Aug 07, 2024	SELL	$262.75 - $319.31 $32,581 - $39,594	-124 Reduced 11.9%	918 $286,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $233,887 - $263,782	1,042 New	1,042 $235,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $272,554 - $319,330	-1,284 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $7,007 - $7,774	-30 Reduced 2.28%	1,284 $313,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $291,589 - $339,800	1,314 New	1,314 $327,000
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $271,902 - $360,616	-1,492 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $157,422 - $202,342	-832 Reduced 35.8%	1,492 $360,000
Q3 2019 Oct 24, 2019	SELL	$174.11 - $208.62 $727,779 - $872,031	-4,180 Reduced 64.27%	2,324 $450,000
Q2 2019 Jul 30, 2019	SELL	$166.7 - $195.41 $257,384 - $301,713	-1,544 Reduced 19.18%	6,504 $1.2 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $81,210 - $91,542	-449 Reduced 5.28%	8,048 $1.53 Million
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $248,868 - $290,508	-1,395 Reduced 14.1%	8,497 $1.65 Million
Q3 2018 Nov 07, 2018	BUY	$185.29 - $208.89 $97,091 - $109,458	524 Added 5.59%	9,892 $2.05 Million
Q2 2018 Jul 27, 2018	BUY	$166.05 - $186.51 $226,658 - $254,586	1,365 Added 17.06%	9,368 $1.73 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $336,826 - $393,624	-1,988 Reduced 19.9%	8,003 $1.36 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $65,659 - $73,361	389 Added 4.05%	9,991 $1.74 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $1.61 Million - $1.83 Million	9,602	9,602 $1.79 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.

Account

Pegasus Partners Ltd. Amgen Inc Transaction History